Yearly incidence of acute childhood gastroenteritis in Nigeria: Implicated pathogens predominantly harbor blaCTXM and blaTEM genes
DOI:
https://doi.org/10.3855/jidc.18716Keywords:
Bacillus sp, emesis, enterotoxigenic, extended-spectrum beta-lactamases, gastroenteritisAbstract
Background and Objectives: Routine use of antibiotics for infectious diarrhea in children is associated with the risk of increasing antibiotic resistance in developing countries. This work aimed to study the predominant extended spectrum beta-lactamase (ESBL) genes among bacteria pathogens implicated in acute childhood gastroenteritis in a tertiary hospital in Nigeria.
Materials and Methods: The stool samples of children diagnosed with acute gastroenteritis were collected. Isolation and identification of bacterial pathogens from the stool samples using standard microbiological and molecular sequencing methods. Pure cultures of the probable bacteria pathogens were subjected to antibiotics susceptibility profiling using the Kirby-Bauer Disk Diffusion Method and also screened for ESBL and AmpC using the Modified Double Disc Synergy Test. Primers for 5 different ESBL genes associated with beta-lactam antibiotic resistance were amplified and sequenced. Results: Out of the 62 isolates, the highest number of organisms identified within the isolates were Bacillus sp at 38.7% (24) followed by Alcaligenes sp at 37% (23). Resistance to cefepime and ceftazidime were recorded at 50.8% (30) each. Ceftriaxone and cefotaxime were resisted in 47.4% (28) of the isolates. Out of 34 isolates resistant to all the cephalosporins used, 41.2% (14) were ESBL-producing, of which blaCTXM-1 and blaCTXM-2 were detected in 85.7%, while blaTEM was seen in 64.3%.
Conclusions: blaCTXM and blaTEM may be the predominant ESBL genes haboured in the bacteria pathogens implicated in the yearly incidence of acute childhood gastroenteritis in Nigeria. This may be due to the widespread use of antibiotics in treating this disease.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ebuka David, Ikechuku Igwenyi, Ifeanyichukwu Iroha, Eghosa Emumwen, Christian Offor, Okechukwu Orji, Franklyn Igwe, David Obasi, Jeff Nkama, Boniface Oke, Moses Ogbanshi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Funding data
-
International Center for Genetic Engineering and Biotechnology
Grant numbers S_NGA20-01-1